JP2024528705A5 - - Google Patents

Info

Publication number
JP2024528705A5
JP2024528705A5 JP2024503903A JP2024503903A JP2024528705A5 JP 2024528705 A5 JP2024528705 A5 JP 2024528705A5 JP 2024503903 A JP2024503903 A JP 2024503903A JP 2024503903 A JP2024503903 A JP 2024503903A JP 2024528705 A5 JP2024528705 A5 JP 2024528705A5
Authority
JP
Japan
Application number
JP2024503903A
Other languages
Japanese (ja)
Other versions
JPWO2023004308A5 (https=
JP2024528705A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/073884 external-priority patent/WO2023004308A1/en
Publication of JP2024528705A publication Critical patent/JP2024528705A/ja
Publication of JP2024528705A5 publication Critical patent/JP2024528705A5/ja
Publication of JPWO2023004308A5 publication Critical patent/JPWO2023004308A5/ja
Pending legal-status Critical Current

Links

JP2024503903A 2021-07-20 2022-07-19 がんのための治療としてのクレアチン輸送を阻害するための組成物及び方法 Pending JP2024528705A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163223926P 2021-07-20 2021-07-20
US63/223,926 2021-07-20
PCT/US2022/073884 WO2023004308A1 (en) 2021-07-20 2022-07-19 Compositions and methods for inhibiting creatine transport as a treatment for cancer

Publications (3)

Publication Number Publication Date
JP2024528705A JP2024528705A (ja) 2024-07-30
JP2024528705A5 true JP2024528705A5 (https=) 2025-07-25
JPWO2023004308A5 JPWO2023004308A5 (https=) 2025-07-25

Family

ID=84979767

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024503903A Pending JP2024528705A (ja) 2021-07-20 2022-07-19 がんのための治療としてのクレアチン輸送を阻害するための組成物及び方法

Country Status (6)

Country Link
US (1) US20240180912A1 (https=)
EP (1) EP4373582A4 (https=)
JP (1) JP2024528705A (https=)
AU (1) AU2022316200A1 (https=)
CA (1) CA3225305A1 (https=)
WO (1) WO2023004308A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119522225A (zh) 2022-09-29 2025-02-25 广州嘉越医药科技有限公司 大环衍生物及其应用
CN116602948B (zh) * 2023-06-06 2024-12-06 湖南岳靶生物医药有限公司 一种可用于降低膀胱癌细胞耐药性的化合物、组合物及其应用
WO2025114580A1 (en) * 2023-11-30 2025-06-05 National And Kapodistrian University Of Athens N-aminoguanidine derivatives with anticancer activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3736022A3 (en) * 2012-10-31 2021-01-20 The Rockefeller University Treatment and diagnosis of colon cancer
US20180002702A1 (en) * 2014-12-26 2018-01-04 Nitto Denko Corporation Methods and compositions for treating malignant tumors associated with kras mutation
WO2021062157A1 (en) * 2019-09-27 2021-04-01 The Rockefeller University Compositions and methods for treating metastatic gastrointestinal cancer
UA128683C2 (uk) * 2019-10-22 2024-09-25 Люпін Лімітед Фармацевтична комбінація на основі інгібіторів prmt5
JP2023505687A (ja) * 2019-12-11 2023-02-10 インスピルナ,インコーポレーテッド 癌の処置方法

Similar Documents

Publication Publication Date Title
JP2024528705A5 (https=)
BR102022025291A2 (https=)
CL2025003579A1 (es) Sistemas y métodos para la producción de amoníaco
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307044655S (https=)
BY13170U (https=)
CN307044384S (https=)
BY23963C1 (https=)
BY13137U (https=)
BY13135U (https=)
BY13140U (https=)
BY13165U (https=)
BY13176U (https=)
CN307045358S (https=)
BY13175U (https=)